Details
-
Active Ingredient: Tolterodine tartrate 2 mg (equivalent to 1.37 mg tolterodine)
-
Manufacturer: Pfizer Italia S.r.l., Italy
-
Marketing Authorization Holder: Viatris Sdn. Bhd., Malaysia
-
Registration Number (MAL): MAL11075058AZ
-
Packaging: 56 film-coated tablets per pack
Indications
Detrusitol is indicated for the symptomatic treatment of overactive bladder syndrome, characterized by:
-
Urgency
-
Frequency
-
Urge incontinence
These symptoms may occur in patients with overactive bladder syndrome
Instructions for Use
-
Dosage: The recommended dose is 2 mg twice daily (morning and evening).
-
Adjustment for Tolerability: If side effects occur, the dose may be reduced to 1 mg twice daily.
-
Renal and Hepatic Impairment: For patients with impaired renal or hepatic function, the recommended dose is 1 mg twice daily.
-
Administration: Take the tablets with or without food.
-
Missed Dose: If a dose is missed, take it as soon as remembered unless it's almost time for the next dose. Do not take two doses at the same time to make up for a missed dose.
-
Storage: Store in a cool, dry place away from direct sunlight
View more about Detrusitol 2mg Tab - 56's on main site